Skip to content
New issue

Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.

By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.

Already on GitHub? Sign in to your account

UNC Kinome Scan #17

Open
mbhebhe opened this issue Jul 22, 2019 · 9 comments
Open

UNC Kinome Scan #17

mbhebhe opened this issue Jul 22, 2019 · 9 comments

Comments

@mbhebhe
Copy link
Contributor

mbhebhe commented Jul 22, 2019

We sent OSM-S-106, 137 and 126 to UNC Chapel Hill (David Drewry) for a Kinome Scan.
The preliminary results can be found on here.

image

OSM-S-106: Only 2 non-mutant human kinases with POC<10 at the 1 micromolar screening concentration (TYK2 and MAP3K19). A number of other kinases have POC<20. Interestingly, PfCDPK1 has POC=11, so perhaps a decent inhibitor.

OSM-S-137: WEE1 has POC= 0. My guess is that this is a false positive.

OSM-S-126: Data suggests this is a relatively narrow spectrum human FLT3 inhibitor.

They are currently doing the Kd determinations. The potentially potent and selective FLT3 compound is cool. They are intrigued by the TYK2 pseudokinase result. If the Kd confirms they would like to pursue this a little more carefully. (MHT (2/10/19): it has interesting biology, e.g. here and here, but, I think, no inhibitor?)

OSM-S-106: NC1=C2C(C=C(C3=CC(S(=O)(N)=O)=CC=C3)S2)=NC=N1
OSM-S-137: O=S(C1=CC(C2=CC3=NC=NC(N4CCN(CC5=CC=C(F)C=C5)CC4)=C3S2)=CC=C1)(N)=O
OSM-S-126: C12=NC=NC(N3CCOCC3)=C1SC(C4=CC=CC=C4)=C2

@MFernflower
Copy link
Contributor

MFernflower commented Jul 22, 2019 via email

@drc007
Copy link
Contributor

drc007 commented Jul 22, 2019

@mbhebhe Can I just confirm the results.
In the excel table in lab archive the structure of OSM-S-126 is drawn alongside the data for OSM-S-137.

OSM-S-137 has a POC of 75 against PfCDPK1 but also similar activity against 50 other kinases?

@mbhebhe
Copy link
Contributor Author

mbhebhe commented Jul 22, 2019

@drc007 Thanks for pointing that out. I hadn't realised that the structures had been switched. I will contact them to confirm.
With OSM-S-137's activity against PfCDPK1, I don't get what you mean

@MFernflower
Copy link
Contributor

Once we verify structure and retest the morpholine compound perhaps could submit to a database or tool compound supplier like tocris @mbhebhe @drc007

@MFernflower
Copy link
Contributor

Also interesting to note the left hand side of https://en.wikipedia.org/wiki/Quizartinib (FLT3 inhibitor in development) looks a tad bit like our morpholine compound! @mbhebhe @drc007 @mattodd

@mattodd
Copy link
Member

mattodd commented Jan 19, 2021

Hi @Skame161 - here's the kinome scan I was mentioning. Compare and contrast with the predictive modelling that was done..?

@Skame161
Copy link
Contributor

@mattodd Thanks

Hi @mbhebhe -- Relatively new to the project and trying to get a handle on what the data means for which kinases OSM-S-106 is active against. Do we have a summary somewhere that I might have missed and do we know how these compare with which kinases came up in predictive modelling? Thanks and regards.

@mbhebhe
Copy link
Contributor Author

mbhebhe commented Jan 25, 2021

@Skame161
Copy link
Contributor

OK, thank you. I'll take a look.

Sign up for free to join this conversation on GitHub. Already have an account? Sign in to comment
Labels
None yet
Projects
None yet
Development

No branches or pull requests

5 participants